Cover Image
Market Research Report

North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By *Route of Administration ; Application ; End User ; and Country

Published by The Insight Partners Product code 943399
Published Content info 145 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By *Route of Administration ; Application ; End User ; and Country
Published: June 9, 2020 Content info: 145 Pages
Description

Title:
North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By *Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country.

The North America pharmaceutical drug delivery market is anticipated to reach US$ 9,36,148.9 Mn by 2027 from US$ 5,60,491.5 Mn in 2019; the market is projected to grow at a CAGR of 6.8% from 2019 to 2027.

The growth of the North America pharmaceutical drug delivery market is primarily attributed to the increasing prevalence of chronic diseases. However, the high cost of drug delivery device development is among the major factor limiting the growth of the market. Further, growth in drug delivery technology and innovations is expected to have a positive impact on the growth of the North American pharmaceutical drug delivery market in the coming years.

Drug delivery systems are medical devices used to inject drugs or therapeutic chemicals into the body. Several types of the drug delivery systems available in the market include transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular, among others. These systems are enabled with the technologies that are primarily used to have a controlled or targeted delivery of various therapeutic agents for the treatment of multiple diseases.

Many healthcare stakeholders in North American countries are focusing on changing the overall landscape of the oral, topical, transmucosal, subcutaneous, and other markets to deliver better health care. The increasing rate of chronic diseases such as cardiovascular disease (CVD) and diabetes is one of the main factors contributing to the upsurge in pharmaceutical drug delivery industry in North America. Due to the hectic present-day lifestyle, CVDs such as angina pectoris, therosclerosis, and acute myocardial infarction have been acting as a significant cause of mortality, not only in North America but also in the whole world. In Canada, CVDs are the second leading cause of deaths. According to Health Canada, ~1 in 12 Canadians, aged 20 and above, live with a diagnosed heart disease in the country. Moreover, according to the World Heart Federation (WHF), noncommunicable diseases, including cardiovascular diseases, accounted for ~77% of total deaths in Mexico in 2016.

Diabetes is one of the life-threatening chronic diseases with no functional cure, and it can increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with diabetes. As there is a significant increase in diabetes cases worldwide, it is resulting in life-changing complications among the population. According to the International Diabetes Federation (IDF), in 2017, 46 million diabetic patients were reported in North America, which has been expected to reach 62 million by 2045. The disease prevalence is likely to rise by ~35% during the forecast period. Exogenous insulin is usually administered through a subcutaneous route. owing to the above mentioned factors propelling the growth of the pharmaceutical drug delivery market in North America.

In 2019, injectable drug delivery accounted for the largest share in the North American pharmaceutical drug delivery market, based on the route of administration. However, the topical drug delivery segment is estimated to mark the highest CAGR in the market during the forecast period owing to the increasing number of patients with skin diseases and gradual shift in patient preference for novel transdermal delivery systems.

Several significant primary and secondary sources related to this study on the pharmaceutical drug delivery market in North America are Centers For Disease Control And Prevention (CDC), Food and Drug Administration (FDA), Ministry of Health and Prevention (MoHAP), Ministry of Health and Family Welfare (MoHFW), and American Cancer Society (ACS), among others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America pharmaceutical drug delivery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America pharmaceutical drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00011595

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Pharmaceutical Drug Delivery Market - By Route of Administration
    • 1.3.2 North America Pharmaceutical Drug Delivery Market - By Application
    • 1.3.3 North America Pharmaceutical Drug Delivery Market - By End User
    • 1.3.4 North America Pharmaceutical Drug Delivery Market - By Country

2. North America Pharmaceutical Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Pharmaceutical Drug Delivery Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 4.2.1 North America Pharmaceutical Drug Delivery Market - North America PEST Analysis
  • 4.3 Expert Opinion

5. North America Pharmaceutical Drug Delivery Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
  • 5.2 Key Restraints
    • 5.2.1 High Cost of Drug Delivery Device Development
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing R&D Spending for Drug Delivery Devices
  • 5.4 Future Trend
    • 5.4.1 Growth in Drug Delivery Technology and Innovations
  • 5.5 Impact Analysis

6. Pharmaceutical Drug Delivery Market - North America Analysis

  • 6.1 North America Pharmaceutical Drug Delivery Market Revenue Forecasts and Analysis
  • 6.2 Market Positioning of Key Players

7. Pharmaceutical Drug Delivery Market Analysis - By Route of Administration

  • 7.1 Overview
  • 7.2 North America Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
  • 7.3 Oral Drug Delivery
    • 7.3.1 Overview
    • 7.3.2 Oral Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Injectable Drug Delivery
    • 7.4.1 Overview
    • 7.4.2 Injectable Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Topical Drug Delivery
    • 7.5.1 Overview
    • 7.5.2 Topical Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Ocular Drug Delivery
    • 7.6.1 Overview
    • 7.6.2 Ocular Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Pulmonary Drug Delivery
    • 7.7.1 Overview
    • 7.7.2 Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.8 Nasal Drug Delivery
    • 7.8.1 Overview
    • 7.8.2 Nasal Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.9 Transmucosal Drug Delivery
    • 7.9.1 Overview
    • 7.9.2 Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.10 Implantable Drug Delivery
    • 7.10.1 Overview
    • 7.10.2 Implantable Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

8. Pharmaceutical Drug Delivery Market Analysis - By Application

  • 8.1 Overview
  • 8.2 North America Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
  • 8.3 Infectious Diseases
    • 8.3.1 Overview
    • 8.3.2 Infectious Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Cancer
    • 8.4.1 Overview
    • 8.4.2 Cancer: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Cardiovascular Diseases
    • 8.5.1 Overview
    • 8.5.2 Cardiovascular Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Diabetes
    • 8.6.1 Overview
    • 8.6.2 Diabetes: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.7 Respiratory Diseases
    • 8.7.1 Overview
    • 8.7.2 Respiratory Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.8 Central Nervous System Disorders
    • 8.8.1 Overview
    • 8.8.2 Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.9 Autoimmune Diseases
    • 8.9.1 Overview
    • 8.9.2 Autoimmune Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.10 Other Diseases
    • 8.10.1 Overview
    • 8.10.2 Other Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

9. Pharmaceutical Drug Delivery Market Analysis - By End User

  • 9.1 Overview
  • 9.2 North America Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027, (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Home Care Settings
    • 9.4.1 Overview
    • 9.4.2 Home Care Settings: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 ASCs/ Clinics
    • 9.5.1 Overview
    • 9.5.2 ASCs/ Clinics: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Other End Users
    • 9.6.1 Overview
    • 9.6.2 Other End Users: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

10. Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 10.1 North America Pharmaceutical Drug Delivery Market Revenue and Forecasts To 2027
    • 10.1.1 Overview
    • 10.1.2 North America: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 North America Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 North America Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 North America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 US Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 US Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Canada: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Canada Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Canada Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 Mexico: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 Mexico Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 Mexico Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Pharmaceutical Drug Delivery Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

  • 12.1 3M
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Antares Pharma
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 BD
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Pfizer Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Johnson & Johnson Services, Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

L

List Of Tables

  • Table 1. North America Pharmaceutical Drug Delivery Market, by Route of Administration- Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Pharmaceutical Drug Delivery Market, by Application- Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Canada Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Canada Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Mexico Pharmaceutical Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Mexico Pharmaceutical Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Mexico Pharmaceutical Drug Delivery Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Glossary of Terms, Pharmaceutical Drug Delivery Market

List Of Figures

  • Figure 1. Pharmaceutical Drug Delivery Market Segmentation
  • Figure 2. North America Pharmaceutical Drug Delivery Market Overview
  • Figure 3. Injectable Drug Delivery Segment Held Largest Share of Product Segment in Pharmaceutical Drug Delivery Market
  • Figure 4. US Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. North America Pharmaceutical Drug Delivery Market- Leading Country Markets (US$ Mn)
  • Figure 6. North America Pharmaceutical Drug Delivery Market, Industry Landscape
  • Figure 7. North America Pharmaceutical Drug Delivery Market - North America PEST Analysis
  • Figure 8. Pharmaceutical Drug Delivery Market Impact Analysis of Drivers and Restraints
  • Figure 9. North America Pharmaceutical Drug Delivery Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 10. Market Positioning Of Key Players In Global Pharmaceutical Drug Delivery Market
  • Figure 11. North America Pharmaceutical Drug Delivery Market Revenue Share, by Route of Administration (2019 and 2027)
  • Figure 12. Oral Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 13. Injectable Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 14. Topical Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 15. Ocular Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 16. Pulmonary Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 17. Nasal Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. Transmucosal Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 19. Implantable Drug Delivery: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. North America Pharmaceutical Drug Delivery Market Revenue Share, by Application (2019 and 2027)
  • Figure 21. Infectious Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Cancer: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Cardiovascular Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Diabetes: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Respiratory Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Central Nervous Systems Disorders: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Autoimmune Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Other Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. North America Pharmaceutical Drug Delivery Market Share, by End User, 2019 and 2027 (%)
  • Figure 30. Hospitals: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Home Care Settings: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. ASCs/ Clinics: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Other End Users: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. North America: Pharmaceutical Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 35. North America Pharmaceutical Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 36. North America: Pharmaceutical Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 37. US: Pharmaceutical Drug Delivery market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Canada: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Mexico: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Impact of COVID-19 Pandemic in North American Country Markets
Back to Top